As of Apr 17
| +0.09 / +2.22%|
The 1 analysts offering 12-month price forecasts for MusclePharm Corp have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +44.93% increase from the last price of 4.14.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.